Fiscal Period | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|
Period End Date | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
Revenue | 53.64 | 52.89 | 50.87 | 54.25 |
Total Revenue | 53.64 | 52.89 | 50.87 | 54.25 |
Costof Revenue Total | 26.56 | 35.69 | 32.78 | 28.55 |
Gross Profit | 27.08 | 17.20 | 18.08 | 25.70 |
Selling/ General/ Admin Expenses Total | 5.14 | 4.72 | 6.24 | 6.04 |
Depreciation/ Amortization | 1.09 | 1.07 | 1.02 | 1.04 |
Other Operating Expenses Total | 11.26 | 8.08 | 7.22 | 8.43 |
Total Operating Expense | 44.06 | 49.58 | 47.26 | 44.05 |
Operating Income | 9.58 | 3.32 | 3.61 | 10.21 |
Interest Inc( Exp) Net- Non- Op Total | -7.36 | -7.30 | -5.49 | -3.12 |
Other Net | 1.50 | 0.86 | 0.81 | 0.61 |
Net Income Before Taxes | 10.35 | 3.45 | 3.87 | 10.51 |
Provisionfor Income Taxes | 2.55 | 1.00 | 1.03 | 3.33 |
Net Income After Taxes | 7.79 | 2.44 | 2.84 | 7.18 |
Net Income Before Extra Items | 7.79 | 2.44 | 2.84 | 7.18 |
Net Income | 7.79 | 2.44 | 2.84 | 7.18 |
Total Adjustmentsto Net Income | 0.00 | 0.00 | - | - |
Income Availableto Com Excl Extra Ord | 7.79 | 2.44 | 2.84 | 7.18 |
Income Availableto Com Incl Extra Ord | 7.79 | 2.44 | 2.84 | 7.18 |
Diluted Net Income | 7.79 | 2.44 | 2.84 | 7.18 |
Diluted Weighted Average Shares | 0.62 | 0.62 | 0.62 | 0.62 |
Diluted EPS Excluding Extra Ord Items | 12.50 | 3.92 | 4.56 | 11.52 |
Diluted Normalized EPS | 12.50 | 3.92 | 4.56 | 11.52 |
Auro Laboratories Dividend Auro Laboratories Bonus Auro Laboratories News Auro Laboratories AGM Auro Laboratories Rights Auro Laboratories Splits Auro Laboratories Board Meetings Auro Laboratories Key Metrics Auro Laboratories Shareholdings Auro Laboratories Balance Sheet Auro Laboratories Cashflow Auro Laboratories Q1 Results Auro Laboratories Q2 Results Auro Laboratories Q3 Results Auro Laboratories Q4 Results
Top GainersTop LosersIndian IndicesBSE Active StocksNSE Active Stocks